• About Us
  • The Microbial Ark
  • Metabolic & Chemical Diversity
  • Technology 
  • Opportunities
  • Publications
  • BioAustralis 
  • Contact
  • About Us
  • The Microbial Ark
  • Metabolic & Chemical Diversity
  • Technology 
  • Opportunities
  • Publications
  • BioAustralis 
  • Contact
Fuligopyrones from the Fruiting Bodies of Myxomycete Fuligo septica Offer Short-Term Protection from Abiotic Stress Induced by UV Radiation

Fuligopyrones from the Fruiting Bodies of Myxomycete Fuligo septica Offer Short-Term Protection from Abiotic Stress Induced by UV Radiation

by admin | Feb 22, 2024 | Uncategorized

Scott A. Minns, Simon Bowles, Ernest Lacey, John A. Kalaitzis, Daniel Vuong, Mark S. Butler, and Andrew M. Piggott Journal of Natural Products 86, 633-637. Publication Date: January 18, 2023 https://doi.org/10.1021/acs.jnatprod.2c00989 Abstract: The myxomycete Fuligo...
Type-I Hemins and Free Porphyrins from a Western Australian Sponge Isabela sp.

Type-I Hemins and Free Porphyrins from a Western Australian Sponge Isabela sp.

by admin | Feb 22, 2024 | Uncategorized

Samuele Sala, Stephen A. Moggach, Gareth L. Nealon, Jane Fromont, Oliver Gomez, Daniel Vuong, Ernest Lacey and Gavin R. Flematti Mar. Drugs 21, 41-51. Publication Date: December 29, 2022 https://doi.org/10.3390/md21010041 Abstract: Two novel free porphyrins,...
Drug susceptibility testing for oxygen-dependent and oxygen-independent resistance phenotypes in trichomonads

Drug susceptibility testing for oxygen-dependent and oxygen-independent resistance phenotypes in trichomonads

by admin | Feb 22, 2024 | Uncategorized

Alexander Y.F. Lam, Ernest Lacey, Vesna De Petra, Deborah A Williamson, Jan Šlapeta, Aaron R. Jex, Samantha J. Emery-Corbin International Journal for Parasitology S0020-7519(23)00019-X Publication Date: November 26, 2022 https://doi.org/10.1016/j.ijpara.2022.11.010...
Suertides A–C: selective antibacterial cyclic hexapeptides from Amycolatopsis sp. MST-135876v3

Suertides A–C: selective antibacterial cyclic hexapeptides from Amycolatopsis sp. MST-135876v3

by admin | Feb 22, 2024 | Uncategorized

Heather J. Lacey, Rachel Chen, Daniel Vuong, Mark F. Fisher, Ernest Lacey, Peter J. Rutledge & Andrew M. Piggott The Journal of Antibiotics 2022,75, 483–490 Publication Date: July 26, 2022 https://doi.org/10.1038/s41429-022-00544-4 Abstract: Amycolatopsis sp....
Bifurcation drives the evolution of assembly-line biosynthesis

Bifurcation drives the evolution of assembly-line biosynthesis

by admin | Feb 22, 2024 | Uncategorized

Thomas J. Booth, Kenan A. J. Bozhüyük, Jonathon D. Liston, Sibyl F. D. Batey, Ernest Lacey & Barrie Wilkinson Nature Communications 2023, 13 (1), 1-12 Publication Date: June 17, 2022 https://doi.org/10.1038/s41467-022-30950-z Abstract: Reprogramming biosynthetic...
« Older Entries
Next Entries »

Recent Posts

  • Fungal Duel between Penicillium brasilianum and Aspergillus nomius Results in Dual Induction of Miktospiromide A and Kitrinomycin A
  • Drug susceptibility testing for oxygen-dependent and oxygen-independent resistance phenotypes in trichomonads
  • Turonicin A, an Antifungal Linear Polyene Polyketide from an Australian Streptomyces sp.
  • Talcarpones A and B: bisnaphthazarin-derived metabolites from the Australian fungus Talaromyces johnpittii sp. nov. MST-FP2594
  • Discovery and heterologous biosynthesis of glycosylated polyketide luteodienoside A reveals unprecedented glucinol-mediated product offloading by a fungal carnitine O-acyltransferase domain

Recent Comments

No comments to show.

Get in touch with us

+61 2 9757 4515
info@microbialscreening.com
28/54 Percival Road, Smithfield NSW 2164 Australia

Australia’s BioDiscovery Company

Quick Links

Opportunities
The Microbial Ark
Metabolic & Chemical Diversity

Quick Links

Technology 
News
BioAustralis 
Contact

© Microbial Screening Technologies | Privacy Policy | Website by Mustard Design & Digital